Potential acquisition of Scorpion positive for Relay, says Barclays
Barclays says reports of Eli Lilly (LLY) reportedly being in talks to acquire Scorpion Therapeutics has a positive read-through to Relay ...
24/7 Wall St2d
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Eli Lilly is close to acquiring Scorpion Therapeutics, a biotech company specializing in cancer treatments. The initial payment is expected to be around $1 billion, with an additional $1.5 ...
alternativeswatch25m
Andreessen Horowitz and Eli Lilly launch $500m healthcare innovation fund
Andreessen Horowitz (a16z)’s Bio + Health partnered with Eli Lilly and Company to establish the $500 million Biotech ...
FierceBiotech2d
Eli Lilly pushes into pulmonary fibrosis with $99M deal for Mediar's midphase prospect
Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in ...
Eli Lilly: Still Much Room To Ride The Weight-Loss Wave
Eli Lilly's dominance in the GLP-1 market and strong revenue growth forecast make LLY stock a promising investment, with a ...